Aelius Biotech: Funding, Investors & Team (Sep 2026)
Aelius biotech specialise in the development of models of the mucosal surfaces of the human body. We currently have the capability to model the gastrointestinal tract and the airways, and are in the process of developing model systems to simulate the mucosal surfaces of the eye and cervico-vaginal tract.
Aelius Biotech has raised $3.2M across 3 funding rounds on record, the most recent an undisclosed round of $960k announced in Apr 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Aelius Biotech Company Profile and Key Stats
Latest funding round on record: Apr 2025.
Aelius Biotech Funding Rounds
Aelius Biotech raised $1.6M in an undisclosed round announced in Nov 2023.
3 months later, an undisclosed round of $630k was announced in Feb 2024.
1.2 years later, an undisclosed round of $960k was announced in Apr 2025.
Aelius Biotech Founders and Leadership Team
Contact details for the Aelius Biotech team: 1 of 1 has an email address on file.
Start 14-day free trial →Aelius Biotech Funding Compared to Other Biotechnology Startups
Aelius Biotech's latest round of $960k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Aelius Biotech in Biotechnology and Newcastle
Companies Similar to Aelius Biotech
An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
IMU is a discovery engine mapping the immune system to advance precision medicine.
Mykor is a climate tech start-up. It decarbonizes the construction industry by manufacturing carbon-negative…
Neurovalens provides cutting-edge solutions in the realms of neuroscience, bioscience, and neurophysiology.…
Aelius Biotech Funding FAQs
What does Aelius Biotech do?
Aelius biotech specialise in the development of models of the mucosal surfaces of the human body. We currently have the capability to model the gastrointestinal tract and the airways, and are in the process of developing model systems to simulate the mucosal surfaces of the eye and cervico-vaginal tract.
How much funding has Aelius Biotech raised?
Aelius Biotech has raised $3.2M across 3 rounds on record. The most recent is an undisclosed round of $960k announced in Apr 2025.
When did Aelius Biotech last raise funding?
Aelius Biotech's most recent funding round on record is an undisclosed round of $960k, announced in Apr 2025.
Who founded Aelius Biotech?
FundedIQ lists Peter Chater (Founder) at Aelius Biotech.
Where is Aelius Biotech headquartered?
Aelius Biotech is based in Newcastle, Newcastle Upon Tyne, United Kingdom.
How many employees does Aelius Biotech have?
Aelius Biotech is in the 1-10 employee band.
How does Aelius Biotech's funding compare to other Biotechnology startups?
Aelius Biotech's latest round of $960k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's Aelius Biotech Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Aelius Biotech is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.